Complete Loss of EPCAM Immunoexpression Identifies EPCAM Deletion Carriers in MSH2-Negative Colorectal Neoplasia

SIMPLE SUMMARY: Colorectal carcinomas from patients with Lynch syndrome (LS) due to EPCAM deletions show loss of MSH2 expression. The aim of our study was to evaluate the usefulness of EPCAM expression in identifying carriers of EPCAM deletion among patients with MSH2-negative lesions. MSH2 and EPCA...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancers (Basel)
Autori principali: Cuatrecasas, Míriam, Gorostiaga, Iñigo, Riera, Cristina, Saperas, Esteban, Llort, Gemma, Costa, Irmgard, Matias-Guiu, Xavier, Carrato, Cristina, Navarro, Matilde, Pineda, Marta, Dueñas, Núria, Brunet, Joan, Marco, Vicente, Trias, Isabel, Busteros, José Ignacio, Mateu, Gemma, Balaguer, Francesc, Fernández-Figueras, María-Teresa, Esteller, Manel, Musulén, Eva
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7599495/
https://ncbi.nlm.nih.gov/pubmed/33003511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12102803
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi